SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Soligenix
An SI Board Since October 2009
Posts SubjectMarks Bans Symbol
9 5 0 SNGX
Emcee:  Paul Lee Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9I took a few here at $1.60 Lazarus-5/23/2018
8 Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to EvaPaul Lee-3/27/2013
7 Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for tPaul Lee-2/10/2012
6Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec&#Paul Lee-10/25/2010
5Soligenix Announces Publication of Positive Stability Results with RiVax(TM), itPaul Lee-2/2/2010
4Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM),Paul Lee-12/28/2009
3Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the PPaul Lee-12/21/2009
2Thanks for the new thread. Surprised to see such little action from this news.Benny-Rubin-10/17/2009
1Soligenix Announces Initiation of its Confirmatory Phase 3 Clinical Trial of orBPaul Lee-10/15/2009
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News